Protective Effect of S-Methyl Cysteine against Tilmicosin-Induced
Cardiotoxicity in Rats
Mohamed Fahmy Abou
Elazab1, Ghada M Gomaa2 and Walied Abdo3*
1Department
of Clinical Pathology; 2Department of Forensic Medicine
and Toxicology; 3Department of Pathology, Faculty of
Veterinary Medicine, Kafrelsheikh University, 33516, Kafr Elsheikh,
Egypt *Corresponding author:
waliedsobhy@yahoo.com
Abstract
The present study was carried out to investigate
whether S-methyl cysteine (SMC) would ameliorate theacute cardiotoxic effect of tilmicosin antibiotic in treated Wister rats. Thirty-two male rats
were equally divided into four groups: control, SMC (100 mg/kg orally for five
consecutive days), tilmicosin (a single dose, 75 mg/kg BW, S/C on the sixth day)
and SMC+Tilmicosin (pretreated with SMC and co-injected with 75 mg/kg of
tilmicosin at the sixth day). The biochemical results demonstrated marked
increase in serum aspartate transaminase (AST), lactate dehydrogenase (LDH),
creatine kinase (CK) activities and cardiac troponin T (cTnT) concentrations in
tilmicosin-treated rats indicating severe cardiotoxicity. On the other hand,
pretreatment of rats with SMC revealed marked decrease in cardiac biochemical
parameters toward the normal limits. Histopathological findings of the heart
sections revealed multifocal myocarditis in tilmicosin-treated rats meanwhile, (SMC+Tilmicosin)
treated group showed slight vacuolation of myocardial fiber.
Furthermore, the ultrastructure findings
revealed myolysis and necrosis in tilmicosin-treated rats compared with intact
myocardial fiber in (SMC+Tilmicosin) group.